Recent Progress With Filgotinib Plus Latest Partnership Expansion Points To Gilead's New Solid PathSeeking Alpha • 07/16/19
Gilead Pens $5 Billion Research Deal — Why Analysts Still Want A MergerInvestors Business Daily • 07/15/19